Omega Fund Management, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001637359 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $186M (100.0% shares, 0.0% debt)

Holdings (10)

New Positions (1)

ODTX Odyssey Therapeutics Inc. 0.0%

Value $54,128 Shares 2,893 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ODTX	Odyssey Therapeutics Inc.	2,893	$54,128	0.0%	—	—	Common Stock	67613T104

Exited Positions (1)

REPL Replimune Group 1.0%

Value $1.91M Shares 248,672 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
REPL	Replimune Group	248,672	$1.91M	1.0%	—	—	—	76029N106

Decreased Positions (1)

BCAX Bicara Therapeutics Inc. 29.1%

Value $54.1M (+13.7%) Shares 1,822,150 (-23.8%) Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
BCAX	Bicara Therapeutics Inc.	1,822,150 (-23.8%)	$54.1M (+13.7%)	29.1%	—	—	Common Stock	055477103

Unchanged Positions (8)

NUVB Nuvation Bio Inc. 24.7%

Value $45.9M Shares 8,081,089 Est. Cost — Unrealized —

BBNX Beta Bionics Inc. 11.1%

Value $20.62M Shares 1,316,183 Est. Cost — Unrealized —

KMTS Kestra Med Technologies Ltd 14.0%

Value $26M Shares 1,022,149 Est. Cost — Unrealized —

ENGN enGene Holdings Inc. 0.8%

Value $1.516M Shares 876,357 Est. Cost — Unrealized —

BBOT BridgeBio Oncology Therapeutics Inc. 13.5%

Value $25.07M Shares 3,289,661 Est. Cost — Unrealized —

ALMS Alumis Inc. 3.7%

Value $6.789M Shares 241,255 Est. Cost — Unrealized —

SANA Sana Biotechnology, Inc. 1.6%

Value $2.945M Shares 843,750 Est. Cost — Unrealized —

IMA ImageneBio, Inc. 1.4%

Value $2.687M Shares 455,361 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVB	Nuvation Bio Inc.	8,081,089	$45.9M	24.7%	—	—	Common Stock Class A	67080N101
BBNX	Beta Bionics Inc.	1,316,183	$20.62M	11.1%	—	—	Common Stock	08659B102
KMTS	Kestra Med Technologies Ltd	1,022,149	$26M	14.0%	—	—	Common Stock	G52441105
ENGN	enGene Holdings Inc.	876,357	$1.516M	0.8%	—	—	Common Stock	29286M105
BBOT	BridgeBio Oncology Therapeutics Inc.	3,289,661	$25.07M	13.5%	—	—	Common Stock	107924102
ALMS	Alumis Inc.	241,255	$6.789M	3.7%	—	—	Common Stock	022307102
SANA	Sana Biotechnology, Inc.	843,750	$2.945M	1.6%	—	—	Common Stock	799566104
IMA	ImageneBio, Inc.	455,361	$2.687M	1.4%	—	—	Common Stock	45175G207